Multiple Myeloma Ide-cel vs Standard Regimens for Patients With Relapsed and Refractory Multiple Myeloma
Multiple Myeloma Patients With Multiple Myeloma Receiving Salvage Treatment After BCMA-Directed CAR T-Cell Therapy
Multiple Myeloma Myeloma Precursor Disease Among Rescue and Recovery Workers Exposed to the World Trade Center Disaster
Multiple Myeloma ASCO 2022: Adding ASCT to Triplet/Maintenance Therapy for Newly Diagnosed Multiple Myeloma
Multiple Myeloma Reducing Transplant-Related Toxicities in Patients With Multiple Myeloma: Use of Resveratrol and Copper
Multiple Myeloma Updated Analysis of the CANDOR Trial: Carfilzomib, Dexamethasone, and Daratumumab (KdD) vs Carfilzomib/Dexamethasone (Kd) in Relapsed or Refractory Multiple Myeloma
